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Abstract
Background: Glaucoma combined with an extremely shallow anterior chamber and cataracts remains as a
complex condition to deal with. And the emergence of microincision vitrectomy surgery (MIVS) system may
provide an ideal option for the treatment of that. We report a clinical study of surgical outcomes of 23-gauge
transconjunctival pars plana vitrectomy (PPV) combined with lensectomy in the treatment of glaucomatous eyes
with extremely shallow anterior chamber and cataract.
Methods: Prospective, nonrandomized and noncomparative case series study. Consecutive patients with secondary
glaucoma, extremely shallow anterior chamber and cataract were recruited to have combined surgeries of 23-gauge
transconjunctival pars plana vitrectomy and lensectomy. The main outcomes were best corrected visual acuity (BCVA),
intraocular pressure (IOP), anterior chamber depth (ACD), number of anti-glaucoma medications and surgery-
associated complications.
Results: Seventeen consecutive patients with secondary glaucoma, extremely shallow anterior chamber and cataract
were recruited. The mean follow-up was 21.2 ± 8.8 months. Postoperatively, there was no significant improvement of
BCVA (P = 0.25). The mean intraocular (IOP) decreased significantly from 43.14 ± 6.53 mmHg to 17.29 ± 1.80 mmHg
(P < 0.001), and the mean depth of anterior chamber increased significantly from 0.507 ± 0.212 mm to 3.080 ±
0.313 mm (P < 0.001). The mean number of anti-glaucoma medications decreased from 4.1 ± 0.8 to 0.6 ± 0.8
(P < 0.001). No severe vision-threatening intra- or post-operative complications occurred.
Conclusions: Glaucoma with an extremely shallow anterior chamber and cataract can be managed well with the
combined surgeries of 23-gauge pars plana vitrectomy and lensectomy. The surgical procedure is an effective and
safe method to resolve the pupillary block and deepen the anterior chamber.
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Background
Glaucoma combined with an extremely shallow anterior
chamber and cataracts is a complex condition often asso-
ciated with malignant glaucoma, phacomorphic glaucoma,
spherophakia or nanophthalmos. In such patients, the
primary mechanism is anterior dislocation of lens-iris dia-
phragm resulted from pupillary or cilliary blockage [1–5].
Elevated intraocular pressure (IOP) and long-lasting con-
tact of the lens-iris diaphragm to the corneal endothelium
eventually lead to corneal decompensation and severe
impairment of visual function. Therefore, besides control
of the IOP, cataract extraction and anterior chamber for-
mation are considered to be necessary [1, 5]. However, the
crowded anterior chamber poses several difficulties during
phacoemulsification, including poor construction of cor-
neal incision, more endothelial cell loss, iris prolapse, diffi-
cult capsulorhexis and high risk of complications [6, 7].
Previous studies have demonstrated the effectiveness of
vitrectomy combined with lensectomy or phacoemulsifica-
tion in the treatment of malignant glaucoma [6, 8]. How-
ever, conventional 20-gauge vitrectomy system requires
opening of the conjunctiva, which causes extensive con-
junctival scarring [9, 10]. With the rapid development of
surgical instrumentations, the microincision vitrectomy
surgery (MIVS) system provides a promising technique
with multiple advantages over the 20-gauge vitrectomy
system [11–15]. MIVS system (23-gauge or 25-gauge) may
be a feasible alternative to overcome the technical difficul-
ties mentioned above [8–11].
According to the latest literatures, there have been few
studies on the use of 23 or 25-gauge MIVS in the severe
anterior segment eyes diseases. Therefore we conducted
the current study to investigate its potential application
in this series of diseases. In the study, we adopted 23-
gauge transconjunctival PPV combined with pars plana
lensectomy (PPL) in eyes with glaucoma, cataract and
extremely shallow anterior chamber. Considering the
severe irreversible vision defect induced by glaucoma
and possible complications after intraocular lens (IOL)
implantation, IOL was not determined to be implanted
in any eyes of the patients. The aim of the surgery is to
remove the lens and vitreous, create a communication
between the anterior chamber and the vitreous cavity,
and thereby reform the anterior chamber.
Methods
The study was approved by the Institutional Review Board
of Zhongshan Ophthalmic Center affiliated to Sun Yat-sen
Univiersity (Guangzhou, China). And it was performed in
accordance with the World Medical Association’s Declar-
ation of Helsinki. Inclusion criteria for patients included
medically uncontrolled IOP, extremely shallow central and
peripheral anterior chamber and lens nucleus of grade 2or
3. Exclusion criteria were patients with uncontrolled ocular
infection, significant opacity of the cornea, lens nucleus of
grade 4 or harder, severe systemic diseases and those unable
to have scheduled follow-ups. The procedures were fully
explained to each patient, and written informed consent
was obtained from each subject. Written consent of pub-
lishing case details was also obtained from each subject.
Seventeen eyes of 17 consecutive patients were prospect-
ively recruited from January 2011 to February 2013 at
Zhongshan Ophthalmic Center of Sun Yat-sen University.
All eligible patients underwent comprehensive ophthal-
mologic examinations, including best-corrected visual
acuity (BCVA), non-contact tonometry and slit-lamp
microscope. The nuclear sclerosis was graded using the
Lens Opacity Classification System (LOCS III) [16]. The an-
terior chamber angle and anterior chamber depth (ACD)
were examined by ultrasound biomicroscope (UBM Plus,
Model P45; Pardigm Medical Industries, Salt Lake City,
UT, USA). The ACD was defined as the distance between
the posterior corneal surface and the anterior lens surface.
B-scan ultrasonography was performed to determine status
of the vitreous and retina. The axial length was also mea-
sured by A-scan ultrasound biometry.
One hour before surgery, 20 % mannitol was intraven-
ously administered to all the patients. All surgeries were
performed under retrobulbar anesthesia by one experi-
enced ophthalmologist (S.Z) using 23-gauge system
(Constellation Vitrectomy System, Alcon Laboratories,
USA). Transconjunctival incisions were created about
3.0–3.5 mm from the limbus using trocars at the infero-
temporal, superotemporal, and superonasal quadrants.
Using the 23-gauge instruments, the anterior vitreous
was firstly cut off. And then lensectomy was performed
to extract the lens nucleus and cortex. Peripheral lens
capsule was preserved for the secondary implantation of
posterior IOL. Once there was any nucleus fragment
dropping into the vitreous cavity, total vitrectomy was
determined to remove the lens fragments and the re-
sidual vitreous. By means of the previous steps, the
communication between the anterior chamber and the
vitreous cavity was constructed. The anterior chamber
was accessed through the superior trocar and the pupil,
viscoelastic agents were then injected to separate the
peripheral iris-corneal adhesion. As mentioned above,
we determined that IOL implantation would not a feas-
ible option for the patients, so all the eyes were not im-
planted with IOL finally. After all the procedures were
completed, the cannulas were removed. And the inci-
sions were sealed by a single stich with 7–0 Vicryl
sutures if obvious leakage was observed.
Postoperatively, tobramycin, nonsteroidal anti-
inflammatory and dexamethasone eye drops were con-
secutively administered four times daily for 4–6 weeks.
Anti-glaucoma eye drops or oral medicine was adminis-
tered if necessary.
Zhang et al. BMC Ophthalmology  (2016) 16:2 Page 2 of 7
Table 1 The characteristics of 17 patients with secondary glaucoma, extremely shallow anterior chamber and cataract









Pre- Post- Pre- Post- Pre- Post- Pre- Post-
1 65 F os Phaco glaucoma Mature white No HM HM 49.4 16.5 4 0 0.544 2.869 22.77 18
2 41 F os Malig glaucoma 2 Trab+ACF 0.02 0.02 39.5 18.7 4 0 0.317 2.955 21.23 12
3 69 M os Malig glaucoma 3 Trab 0.04 0.05 43.2 18.5 5 1 0.405 2.797 22.27 30
4 71 M os Phaco glaucoma Mature white No HM HM 41.7 17.4 5 0 0.220 2.980 24.83 24
5 59 F os Malig glaucoma 2 Trab+ACF HM FC 42.0 18.9 4 1 0.693 2.750 22.21 30
6 63 F od Malig glaucoma 3 Trab+ACF 0.04 0.02 38.5 18.2 3 0 1.050 3.463 22.30 36
7 67 M os Malig glaucoma 3 Trab HM HM 49.8 17.5 5 2 0.762 2.676 23.85 18
8 68 F os Spherphakia, glaucoma 2 No FC 0.02 35.3 17.3 3 0 0.580 3.581 21.60 24
9 45 F od Uveitis, glaucoma 3 LPI LP FC 41.4 14.7 4 0 0.261 3.069 23.49 30
10 58 F od Malig glaucoma 3 Trab FC 0.02 50.9 16.2 5 1 0.630 2.750 21.72 18
11 42 F od Uveitis, glaucoma 3 LPI HM FC 33.6 16.1 4 0 0.378 2.823 21.62 24
12 40 F od Malig glaucoma 2 Trab HM HM 37.5 15.4 3 0 0.542 2.951 21.94 12
13 62 M od Phaco glaucoma Mature white No HM FC 42.8 20.8 3 1 0.460 3.520 22.31 36
14 57 M os Malig glaucoma 2 Trab+ACF HM FC 60.3 18.5 5 2 0.635 2.962 21.98 12
15 44 F od Spherphakia, glaucoma 2 no 0.02 0.02 39.4 15.7 4 0 0.322 3.551 21.67 9
16 50 F os Malig glaucoma 2 Trab+ACF FC FC 42.7 14.1 5 1 0.524 3.360 22.10 15
17 57 M os Malig glaucoma 3 Trab HM FC 45.3 19.5 4 2 0.295 3.298 21.45 12
BCVA best-corrected visual acuity; CF counting fingers; HM hand motion; M male; F female; ACD anterior chamber depth; AL axial length; IOP intraocular pressure; Trab trabeculectomy; LPI laser peripheral iridectomy;













Follow up examinations were scheduled at 1 week,
1 month, 3 months, 6 months, and 1 year after the sur-
gery. If necessary, extra revisits were performed. At each
postoperative visit, BCVA was assessed with Snellen
visual charts, IOP was measured by non-contact tonom-
etry, slit-lamp microscope and ophthalmoscope were
performed, and the number of anti-glaucoma medica-
tions being used was also recorded. All the postoperative
ACD was examined by anterior segment coherence tom-
ography (AS-OCT, VisanteTM; Carl Zeiss Meditec,
Dublin, CA, USA). In the aphakic eyes, the ACD was
defined as the distance between the posterior corneal
surface and the plane of the pupil. Improved VA was
defined as improvement of more than one Snellen line,
same as within one line and worse as loss of more than
one Snellen line.
All Snellen visual acuity values were converted to the
logarithm of the minimum angle of resolution (logMAR)
for statistical analysis. Visual acuity of light perception
(LP) was assigned as 2.9 logMAR, hand movements
(HM) as 2.6 logMAR, and counting fingers (CF) as 2.3
logMAR. All data were analyzed using the SPSS 13.0
statistical software (SPSS Inc., Chicago, IL, USA). The
Shapiro normality test was performed on all the con-
tinuous data. Paired t-test and Wilcoxon matched-pairs
signed rank test were used as appropriate. All the
continuous data were expressed as mean ± standard
deviation (SD). A P value less than 0.05 was considered
statistically significant.
Results
There were totally 17 consecutive patients (17 eyes) in-
cluded in the study, with 10 eyes (58.8 %) diagnosed as
malignant glaucoma, three eyes (17.6 %) as phacomorphic
glaucoma, two eyes (11.8 %) as glaucoma secondary to
spherophakia and two eyes (11.8 %) as glaucoma secondary
to uveitis. The mean age of the patients was 56.35 years
(range 40–71 years). Previous surgical interventions in-
cluded trabeculectomy in ten eyes, anterior chamber refor-
mation in five eyes, and laser peripheral iridectomy in two
eyes. The lens nucleus density was classified from grade 2
in seven eyes (41.2 %) to grade 3 in seven eyes (41.2 %) and
mature white cataract was diagnosed in three eyes (17.6 %).
The mean axial length was 22.31 ± 0.94 mm (range 21.23–
24.83 mm). The mean postoperative follow-up duration
was 21.2 ± 8.8 months (range 9–40 months). The baseline
characteristics of all patients were summarized in Table 1.
A typical case (Case 9) was demonstrated in Fig. 1.
Preoperatively, the BCVA was 8/200 in two eyes
(11.8 %), 4/200 in two eyes (11.8 %), CF in three eyes
(17.6 %), HM in nine eyes (52.9 %), and LP in one eye
(5.9 %). At the final visit, the BCVA was 10/200 in one
eye (5.9 %), 4/200 in five eyes (29.4 %), CF in seven eyes
(41.2 %), HM in four eyes (23.5.8 %). The preoperative
and postoperative logMAR BCVA had no statistical
difference (2.32 ± 0.47 VS 2.28 ± 0.42) (P = 0.25).
The mean IOP was 43.14 ± 6.53 mmHg (range 33.6–
60.3 mmHg) preoperatively, which significantly de-
creased to 21.12 ± 4.76 mmHg (P < 0.001) at 1 day and
Fig. 1 A 45-year-old man presented with glaucoma secondary to uveitis in his right eye (Case 9). Before surgery: a anterior segment photograph
shows marked iris atrophy and pupillary occlusion. b slit lamp biomicroscopy examination revealed an extremely shallow anterior chamber. The central
ACD was 0.261 mm. One week after surgery: c The image on the left demonstrates a quiet anterior chamber and a relative normal pupil. d The slit
lamp photography shows a significantly deep anterior chamber. The central ACD has increased to 3.069 mm at the center after 23-gauge PPV and PPL
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20.28 ± 4.85 mmHg (P < 0.001) at 7 days postopera-
tively. One month after the surgery, the mean IOP of
17.45 ± 2.42 mmHg was maintained with/without top-
ical anti-glaucoma medications. However, a slow ele-
vation of IOP was observed in two eyes during the
follow-up (Case 9 and Case 11), which underwent
glaucoma valve implantation due to the failure of IOP-
lowering medications. At the final visit, the mean IOP
was 17.29 ± 1.80 mmHg (range 14.4–20.8 mmHg) in
17 eyes. Changes in IOP measurements during the
follow-up were shown in Fig. 2.
With regard to anti-glaucoma medications, patients were
administered a mean of 4.1 ± 0.8 (range 3–5) medications
before surgery. At the last follow-up, anti-glaucoma medi-
cations had decreased significantly to 0.6 ± 0.8 (range 0–2)
(P < 0.001). And nine eyes (52.9 %) maintained the IOP in a
normal range without any anti-glaucoma eye drops.
The mean preoperative ACD was 0.507 ± 0.212 mm
(range 0.220–1.05 mm). At the final follow-up, the mean
ACD was 3.080 ± 0.313 mm (range 2.676–3.581 mm),
which was statistically significant compared with the
preoperative one (P < 0.001).
There were no severe perioperative complications
occurred. During the surgery, slight iris hemorrhage oc-
curred in one eye (Case 9) during the separation of iris
posterior synechia, but it stopped soon after temporarily
rising of irrigation pressure. Peripheral retinal hole was
found in one eye, which subsequently received retinal
laser photocoagulation. At the end of the surgery, four
eyes (23.5 %) required suturing to stop visible leakage at
the sclerotomy sites. No postoperative complications
such as hypotony, conjunctival leakage, corneal decom-
pensation, endophthalmitis, suprachoroidal hemorrhage,
vitreous hemorrhage, choroidial detachment, or retinal
detachment were observed. Failure of pre-existing filter-
ing bleb was not found in any eyes.
Discussion
Although this study enrolled patients with different types of
glaucoma, the common features of all were medically un-
controlled IOP (43.14 ± 6.53 mmHg) and extremely shallow
anterior chamber (0.507 ± 0.212 mm). In our case series,
lens extraction was considered to be the definite treatment
to deepen the anterior chamber and relieve pupillary block.
However, the crowded anterior chamber disturbs the surgi-
cal manipulation of phacoemulsification in such eyes. The
peripheral iridocorneal apposition makes it difficult to
properly construct a clear corneal incision. The narrow
anterior chamber puts the cornea under higher risk of
damage by ultrasound waves and/or mechanical contact of
the surgical instruments. Additionally, corneal edema and
pupillary abnormities are commonly found in this kind of
patients, both of which may increase the difficulty of capsu-
lorhexis [6, 7]. Consequently, clear corneal phacoemulsifi-
cation was considered to be fraught with higher risk of
intra- and postoperative complications in our case series.
In such instance, PPV combined with PPL may be a rela-
tively safer manipulation. Using vitrectomy cutter, cataract
can be managed with enough working space from vitreous
cavity. The lens was extracted by mechanical cutting, which
exert less damage to the corneal endothelial cells as
compared to ultrasound energy in phacoemulsification.
Moreover, there was less need of repeated exchange of
instruments, which would reduce IOP fluctuation during
the procedure. In the current study, 23-gauge vitrectomy
instrumentations were adopted to remove cataract and
anterior vitreous through the transconjunctival incision.
The main advantage of 23-gauge system is that incision of
the conjunctiva is not required, which reduces operating
times, minimizes conjunctiva trauma, and decreases post-
operative inflammation [12–15]. Considering the rigidity
and effectiveness of its instrumentations, 25-gauge system
was not used in the present study.
According to our data, the combined surgery was ef-
fective in relieving the pupil block and reforming the an-
terior chamber. Intraoperatively, we observed significant
deepening of the anterior chamber and elimination of
aqueous blockade in all eyes. At the final revisit, the an-
terior chamber was maintained well with a mean depth
of 3.080 mm. In our case series, the majority of patients
(58.8 %) were diagnosed as malignant glaucoma. Previ-
ous studies have reported that PPV is an effective treat-
ment to break the cycle of aqueous misdirection.
However, several reports showed that the recurrence of
malignant glaucoma is more likely in phakic eyes under-
gone PPV alone (26 ~ 75 %) compared with pseudo-
phakic eyes and those received PPV and PPL (0 ~ 17 %)
[8–10]. For these reasons, it is concluded that vitrectomy
combined with lens extraction provide therapeutic ad-
vantage in phakic eyes with malignant glaucoma. In our
surgical procedure with 23-gauge vitrectomy system,
Fig. 2 IOP changes before and after 23-gauge PPV and PPL
(* = presence of statistical significance to the preoperative IOP)
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PPV and PPL were performed via the same transconjunc-
tival sclerotomies without the creation of corneal incision.
During the mean follow-up of 21.2 months, none of the
patients suffered a recurrence of aqueous misdirection.
Although the anterior chamber was effectively deepened
in all eyes, the aqueous outflow route was not successfully
reconstructed in some cases due to the extensive periph-
eral anterior synechia or irreversible trabecular injury.
Despite an initial normalizing of the IOP with/without
anti-glaucoma medications in all patients, we observed a
slow increase of IOP in two eyes with initial diagnosis of
uveitis. During the follow-up period, implantations of
Ahmed valve drainage device (New World Medical,
Rancho Cucamonga, CA, USA) were eventually per-
formed in these eyes (Case 9 and Case 11). Un Chul Park
et al. reported that the success rate of Ahmed valve im-
plantation in the vitrectomized group was similar to that
of the nonvitrectomized group [17]. Nevertheless, conven-
tional 20-gauge vitrectomy has been reported to cause
conjunctiva scarring and recession in multiple quadrant,
which may induce impairment of the pre-existing filtering
bleb or exert challenge to the further glaucoma surgery
[18]. In the current study, we found that the conjunctival
adhesion caused by 23-gauge trocar was minimal, which
didn’t disturb the implantation of the drainage device.
Moreover, there was no suturing-associated failure of pre-
existing filering bleb observed in our cases series. At the
end of the follow-up, the mean IOP was 17.29 ±
1.80 mmHg with no need of glaucoma medications in
52.9 % of eyes.
The major complication of MISV is postoperative hypot-
ony (IOP < 5 mmHg) resulted from leaking sclerotomies.
As previously reported, the incidence of postoperative
hypotony was 2.6 % after 23-gauge vitrectomy and 3.8 to
20 % after 25-gauge MIVS. [19–22] Postoperative hypotony
can precipitate the occurrence of delayed subchoroidal
hemorrhage, the incidence of which is 10-fold greater than
that in the intraoperative period [23, 24]. In the present
study, postoperative hypotony was not found in any of the
case. The mean IOP was 21.12 ± 4.76 mmHg at 1 day and
20.28 ± 4.85 mmHg at 7 days after the surgery. The meticu-
lous checks for the leaking sclerotomy and appropriate
suturing were considered as the main causes of the low
incidence of postoperative hypotony in our case series. The
rate of sclerotomy suturing in this study was 23 %, which
was higher than that reported by the available literatures
(1.3–11.2 %) for 23-gauge vitrectomy [20, 25, 26]. The
possible explanation was that vitreous base dissection was
performed more thoroughly in most cases, which resulted
in poorer closure due to the reduced “plugging effect” of
remnant vitreous under the sites of sclerotomy. The scler-
otomies were sutured by single-needle stitch to minimize
the scar formation of corresponding conjunctiva. In our
case series, the stable postoperative IOP may explain the
low rate of complications including suprachoroidal
hemorrhage, vitreous hemorrhage, choroidial detachment,
and retinal detachment.
As described by Liu et al., phacoemulsification-
posterior capsulorhexis–anterior vitrectomy– intraocular
lens (IOL) implantion was performed in patients with
phakic malignant glaucoma, which helped to improve
the postoperative visual acuity [27]. Howerver, according
to our data, the preoperative visual acuity was quite poor
(2.32 ± 0.47) and 88.2 % eyes had BCVA of 20/400 or
worse. The main causes of reduced vision in our patients
were corneal edema, cataract, and glaucomatous optic
nerve damage. Even after removal of lens, no significant
increase in the mean BCVA was observed at the end of
the follow-up. Owing to the little benefit of visual func-
tion achieved from the surgery, the goal of our surgery is
to reform the anterior chamber, decrease the IOP and
preserve existing vision. Therefore, the IOL was not
determined to be implanted in our cases, which might
reduce the surgery manipulation and the risks of
complications.
Despite the advantages mentioned above, our study also
has some limitations. One drawback was that ultrasonic
fragmatome is not available in the 23-gauge vitrectomy
system. It is almost impossible to manipulate the lens
nucleus more than grade 4 using 23-gauge vitrectomy
cutter. For this reason, eyes with lens nucleus of grade 4
or harder was considered as contraindication for this
microincision technique, and thus not included in this
study. This limitation may be resolved by the advance-
ment in surgical instrumentation. More recently, Spierer
et al. describe the application of a 20-gauge transconjunc-
tival vitrectomy trocar system, which may offer combined
20-gauge fragmatome and 23-gauge vitrectomy for the
management of denser lens nucleus in such eyes [28].
Conclusion
In conclusion, our findings showed that the 23-gauge
transconjunctival PPV combined with PPL was relatively
safe and effective in the management of patients with
glaucoma, extremely shallow anterior chamber and cata-
ract. Definite anterior chamber formation and IOP re-
duction could be achieved by the combined surgical
approach, with preservation of residual vision and de-
crease of anti-glaucoma medications. The procedure
could be considered as a therapeutic option for eyes with
poor visual function and no plan of IOL implantation.
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